Scientech Corporation to Showcase Integrated Biomedical and Analytical Instrument Solutions at BIO A
Exhibitor: SCIENTECH CORPORATION
Date: 2026-05-25
Booth No.: L1126
Scientech Corporation to Exhibit at BIO Asia-Taiwan 2026
Focusing on Cell Research, Nanoparticle Analysis, Real-Time Gas Analysis, and Advanced Surface Measurement Technologies from SemiLab
[Biotech News] Scientech Corporation will participate in BIO Asia-Taiwan Exhibition 2026 from July 16 to July 19, 2026, at Taipei Nangang Exhibition Center, Hall 1, 4F, Booth L1126. Under the theme of research instrumentation spanning cell science, materials characterization, and process analysis, Scientech will integrate a wide range of international brands and application-driven solutions to support academic institutions, biotechnology companies, pharmaceutical R&D teams, materials science laboratories, and analytical testing facilities in improving research efficiency and data quality.
This year, Scientech will showcase multiple international instrument brands, including TAIHOYA, Berghof, ECHO, CAI ENVEA Group, ELTRA, FlowVIEW, Fritsch, Otsuka, Thermo Fisher Scientific, Particle Metrix ZetaView, Syft Technologies, and SemiLab. The exhibition will cover a broad range of applications, including dynamic cell culture, single-cell isolation, nanoparticle size and zeta potential analysis, extracellular vesicle and nanoparticle tracking analysis, real-time VOC gas analysis, elemental analysis, high-pressure reaction and sample preparation, chromatography analysis, gas monitoring, and biodegradation analysis.
One of the key highlights of this year’s exhibition is Scientech’s newly introduced advanced research and surface measurement solutions from SemiLab, including spectroscopic ellipsometry, atomic force microscopy (AFM), quartz crystal microbalance (QCM), and CellSorter single-cell picking and isolation systems. SemiLab’s technologies support thin-film thickness and optical property analysis, nanoscale surface morphology and roughness measurement, molecular adsorption and interfacial interaction studies, and high-resolution single-cell selection. These solutions provide more comprehensive analytical tools for biomedical materials, regenerative medicine, cell therapy, extracellular vesicle research, drug development, and cross-disciplinary applications in semiconductor and materials science.
For cell research and regenerative medicine applications, Scientech will continue to showcase the TAIHOYA ATMS dynamic cell and tissue culture system, which can simulate mechanical stimulation conditions such as stretching and compression. The system helps researchers investigate cellular responses under dynamic microenvironmental conditions and is suitable for mechanobiology, tissue engineering, inflammatory response studies, osteoarticular research, and regenerative medicine. When combined with SemiLab’s CellSorter single-cell isolation technology, the workflow can be further extended to single-cell selection, cell line development, rare cell research, and downstream genetic analysis.
For nanoparticle and extracellular vesicle analysis, Scientech will also present the Particle Metrix ZetaView® nanoparticle tracking analyzer, Otsuka nanoparticle size and zeta potential analyzers, and Fritsch laser particle size analyzers. These solutions help researchers characterize particle size, concentration, dispersion behavior, and surface charge from the nanometer to micrometer scale. They are applicable to extracellular vesicles, lipid nanoparticles, drug delivery carriers, colloidal materials, powder dispersion, and quality control applications.
To address process, environmental, and gas analysis needs, Scientech will also showcase solutions such as the Syft SIFT-MS real-time trace VOC analyzer, CAI ENVEA Group gas monitoring systems, ECHO biodegradation analyzers, and ELTRA elemental analyzers. These technologies support real-time gas monitoring, volatile organic compound analysis, carbon/hydrogen/nitrogen/sulfur/oxygen elemental analysis, and the evaluation of material or product degradation properties.
Scientech noted that biomedical research is rapidly moving toward cross-disciplinary integration, and a single instrument is often no longer sufficient to meet the full range of needs from materials, cells, nanocarriers, and process quality control. Therefore, at this year’s BIO Asia-Taiwan Exhibition, Scientech will not only present individual instruments, but also focus on application-oriented workflows to help customers build more complete analytical processes. For example, extracellular vesicle research can integrate particle size, concentration, and zeta potential analysis; regenerative medicine studies can combine dynamic cell culture, single-cell isolation, and downstream molecular analysis; and biomedical materials development can integrate ellipsometry, AFM, QCM, and particle size analysis to establish a more complete evidence chain from surface properties to cellular responses.
Scientech sincerely invites researchers and professionals from biotechnology, biopharmaceuticals, regenerative medicine, materials science, pharmaceutical development, environmental testing, food and health products, and academic research institutions to visit Booth L1126 and meet with Scientech’s Chemical and Biotechnology team. Whether for new laboratory setup, optimization of existing analytical workflows, instrument evaluation, or cross-disciplinary research platform planning, Scientech can provide technical consultation and application-based recommendations according to user needs.
Exhibition Information
Exhibition: BIO Asia-Taiwan Exhibition 2026
Date: July 16–19, 2026
Venue: Taipei Nangang Exhibition Center, Hall 1, 4F
Scientech Booth: L1126
Exhibiting Brands: TAIHOYA, Berghof, ECHO, CAI, ELTRA, FlowVIEW, Fritsch, Otsuka, Thermo, ZetaView, Syft, SemiLab
Company Website: www.scientech.com.tw
More Exhibitor's Press Release
- AniFree™ Opens a New Era of Preclinical Inhalation Research AEPROMED INNOVATION CORP., LTD. / 2026-05-25
- Voice AI-Assisted Early Dementia Screening — KVQ Intellect Pioneers a New Trend in Medical AI KVQ INTELLECT CO., LTD. / 2026-05-25
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-05-25
- AI-MindSnap voice rapid screening, protecting brain health in 1 minute. KVQ INTELLECT CO., LTD. / 2026-05-25
- 2025 Taiwan Takes the Lead, Reaching New Heights – KVQ Intellect: Turning a Voice into the Beginning KVQ INTELLECT CO., LTD. / 2026-05-25
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-05-25
- BrainChild XH13 Cloud Logger Delivers Environmental Visibility for Labs and Storage BRAINCHILD ELECTRONIC CO., LTD. / 2026-05-25
- PapiVax Biotech’s PVX4 Receives TFDA Approval for Phase II Clinical Trial in Taiwan PAPIVAX BIOTECH INCORPORATED / 2026-05-25
- NeoFlow™ Launches “AeroMesh Shield™” A New Near-Source PM2.5 Protection System for High-Dust Occupat WEJION CO., LTD. / 2026-05-24
- Japanese Regenerative Medicine Focuses on Knee Joint Care in Aging Societies ASIA WORLD INTERNATIONAL INDUSTRY CORP. / 2026-05-24
- Japan Ocean Health to Present Premium Medical Services in Japan at BIO Asia ASIA WORLD INTERNATIONAL INDUSTRY CORP. / 2026-05-24
- CLINIQUE Haru Showcases Japanese Regenerative Medicine at BIO Asia ASIA WORLD INTERNATIONAL INDUSTRY CORP. / 2026-05-24
- Noah AI: An AI Agent Built for Life Sciences SHANGHAI NOAH AI TECHNOLOGY CO., LTD. / 2026-05-22
- Noah AI Develops AI Clinical Expert to Support End-to-End Clinical Trial Workflows SHANGHAI NOAH AI TECHNOLOGY CO., LTD. / 2026-05-22
- Noah AI Announces AI Scientist, Its Upcoming Platform for Scientific Research SHANGHAI NOAH AI TECHNOLOGY CO., LTD. / 2026-05-22
- TALENT CRO: Your Trusted Partner for Comprehensive Clinical and Regulatory Solutions TALENT CRO INC. / 2026-05-22
- GPSR_M2 Plus Advances Low-Temperature Microplasma Wound-Care Applications E_SUI MEDICAL INNOVATION TECHNOLOGY CO., LTD. / 2026-05-21
- AeproMED’s NEBreath™ Receives TFDA Medical Device Approval AEPROMED INNOVATION CORP., LTD. / 2026-05-19
- From Hospital to Home: AeproMED Partners with NTU Hospital Yunlin Branch to Advance Smart Inhalation AEPROMED INNOVATION CORP., LTD. / 2026-05-19
- Alar announces the US phase 1 study results of ALA-3000 for treatment-resistant depression ALAR PHARMACEUTICALS INC. / 2026-05-18